BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Scientists captured female sperm whales on video working together during a birth to protect the calf - 2The most effective method to Execute a Lung-Solid Eating routine After a Cellular breakdown in the lungs Finding
- 3Colleges say foreign students feel 'unwelcome' in the U.S. amid big drop in international enrollment, new survey finds
- 4Father and son spending Christmas together after health scares
- 5Grasping the Course of Evacuation and Extradition in U.S. Migration
- Former defense minister Gallant vacated home over security threat under Shin Bet direction
- Behind every perfect holiday memory is a mom on the brink
- NASA releases stunning new images captured by the Artemis II moon mission, including 'Earthset' and a solar eclipse from space
- IDF kills senior PIJ Gaza City Brigade cmdr. who infiltrated Kibbutz Nahal Oz on Oct. 7
- Key Business Regulations to Consider While Arranging Your Independent venture
- Treason trial of South Sudan's suspended VP is further eroding peace deal, UN experts say
- Birds Will Flock To Your Birdbath When You Plant These Two Flowers Around It
- Fossils unearthed in Morocco are first from little-understood period of human evolution
- California warns of death cap mushrooms outbreak resulting in 3 deaths
